Desloratadine in the treatment of chronic idiopathic urticaria

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 56, Issue 65, 2001, Pages 28-32

  Ring, J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allergic cascade; Chronic idiopathic urticaria; Desloratadine

Indexed keywords

ANTIHISTAMINIC AGENT; CELL ADHESION MOLECULE; CYTOKINE; DESLORATADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

AUTOIMMUNE DISEASE; CHRONIC URTICARIA; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IDIOPATHIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REVIEW; SKIN DISEASE; SYMPTOM;

CHOLINERGIC ANTAGONISTS; CHRONIC DISEASE; CYTOKINES; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; URTICARIA;

EID: 0035137057     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. The pathogenesis of chronic idiopathic urticaria
2. Urticaria: Then and now
3. Chronic urticaria
4. Antihistamines in urticaria
5. The impact of chronic urticaria on the quality of life
6. 2 antagonists in allergic and pseudoallergic diseases
7. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions
8. Assessment of tissue fluid histamine levels in patients with urticaria
9. Upregulation of tumor necrosis factor α and interleukin-3 expression in lesional and uninvolved skin in different types of urticaria
10. Comparative cytokine gene expression: Regulation and release by human mast cells
11. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria
12. Detection of circulating histamine releasing autoantibodies with functional properties of an anti-IgE in chronic urticaria
13. Chronic urticaria
14. Low dose cyclosporin A in the treatment of severe chronic idiopathic urticaria
15. 1-receptor antagonist. 1st communication: Receptor selectivity, antihistaminic activity, and antiallergic effects
16. 1-receptors
17. 1-receptor antagonist with antiallergic activity
18. 1 antihistamine
19. Desloratadine and alcohol co-administration: No increase in impairment of performance over that induced by alcohol alone
20. Desloratadine does not impair actual driving performance: A 3-way crossover comparison with diphenhydramine and placebo
21. 1-antagonist, desethoxycarbonyl-loratadine
22. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI + cells
23. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine
24. 2-receptor antagonists
25. 1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines
26. Loratadine reduces RANTES release by an epithelial cell line
27. Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells
28. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
29. Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation